This study is looking at how Spinal Cord Stimulators (SCS) might help improve blood vessel changes in people with type 2 diabetes. Specifically, it aims to see if SCS can improve blood flow in the lower legs for patients who have painful diabetic nerve damage and are already scheduled to get an SCS. Researchers will measure improvements in blood vessel health using tests like the Ankle Brachial Index (ABI) and Toe Brachial Index (TBI) after 6 weeks. You might be able to join if you are at least 18 years old, have had type 2 diabetes for over a year, and have painful diabetic nerve damage in your lower legs with an ABI less than 0.9. The study is currently unclear on its recruitment status.

Study design

This is an observational pilot study with a planned enrollment of 25 participants. It is a single-center study.

What's involved

You would have a baseline visit with questionnaires and evaluations, followed by vascular tests before your spinal cord stimulator implantation.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 6 weeks to measure improvements in vascular changes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.